Try GOLD - Free
Indian Firms Ramp Up Bulk Drug Mfg
Hindustan Times Bengaluru
|March 17, 2025
Indian companies have started manufacturing important bulk drugs or active pharmaceutical ingredients (APIs) under the government's production linked incentive (PLI) scheme.
NEW DELHI:
The production of Penicillin G and Clavulanic Acid began in October last year. Other APIs already in production include Atorvastatin, Sulfadiazine, Telmisartan, Olmesartan, Para Amino Phenol (raw material for paracetamol) and Oxcarbazepine.
The development is set to make India less reliant on China for imports of raw material used by the pharmaceutical industry.
This story is from the March 17, 2025 edition of Hindustan Times Bengaluru.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Hindustan Times Bengaluru
Hindustan Times Bengaluru
SCOTT ADAMS, THE 'DILBERT' CARTOONIST, DIES AGED 68
Scott Adams, whose popular comic strip “Dilbert” captured the frustration of beleaguered, white-collar cubicle workers and satirised the ridiculousness of modern office culture until he was abruptly dropped from syndication in 2023 for racist remarks, has died.
1 min
January 14, 2026
Hindustan Times Bengaluru
Founders of RedTape seek stake sale
Indian footwear firm RedTape's founders are soliciting interest from Blackstone and KKR as they look to sell a majority stake or even their entire holding worth nearly $510 million, according to people familiar with the matter and a document seen by Reuters.
1 mins
January 14, 2026
Hindustan Times Bengaluru
B'desh again tells ICC to shift WCT20 games out of India
.. BCB’s position remains unchanged. Both parties agreed that discussions will continue to explore possible solutions
1 mins
January 14, 2026
Hindustan Times Bengaluru
Reddy and Badoni jostle for Sundar’s spot in ODI squad
Indian batters will look to impose themselves against New Zealand in batting-friendly Rajkot
3 mins
January 14, 2026
Hindustan Times Bengaluru
Justice Swaminathan, a lamp-lighting order and a fiery row
In recent weeks, justice GR Swaminathan’s name has been everywhere, surfacing more often in parliamentary rhetoric than in law reports.
5 mins
January 14, 2026
Hindustan Times Bengaluru
Panel on digital arrests looks at fixing liability for citizens’ losses
The Centre has constituted a high-level Inter-Departmental Committee to tackle digital arrest scams, with the panel deciding in its first meeting that victims should not bear losses attributable to negligence by banks, telecom providers or other regulated entities, the government informed the Supreme Court in a status report filed on Tuesday.
3 mins
January 14, 2026
Hindustan Times Bengaluru
Turmoil in Tehran and its geopolitical aftershocks
The crisis in Iran is a stress test for West Asia. New Delhi must balance its cautious neutrality with pragmatic engagement, prioritising stability and access over alignment
4 mins
January 14, 2026
Hindustan Times Bengaluru
'India’s culture, Sanatan Dharma can't be erased'
It is not so easy to erase India’s Sanatan Dharma, its culture, and the faith of the Indian people, Union home minister ‘AmitShah said on Tuesday, citing the reconstruction of the Somnath temple in Gujarat despite being “destroyed 16 times”.
1 mins
January 14, 2026
Hindustan Times Bengaluru
Cut-off percentile for NEET-PG ‘0’ for reserved applicants
EXPERTS SAID THE DECISION, WHICH WILL APPLY TO THE THIRD ROUND OF COUNSELLING, SIGNALS A DECLINE IN ACADEMIC STANDARDS
1 mins
January 14, 2026
Hindustan Times Bengaluru
ITC’s Sachin Sahay top pick for Birla Opus CEO
Sachin Sahay, executive vice-president—sales operations at ITC Ltd, has emerged as the frontrunner to take over as chief executive officer of the Aditya Birla Group-backed Birla Opus, the disruptor in India’s ₹70,000-crore paints market, according to two people aware of the development.
1 min
January 14, 2026
Listen
Translate
Change font size